bilateral M1-iTBS

intermittent theta-burst stimulation targeting primary motor cortex

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for bilateral M1-iTBS, covering 2025-02-21 to 2025-02-21. Get the full timeline:

Most recent: Clinical Trial Update: Biomarkers of Neurodegeneration and Neuroplasticity in Parkinson's Disease Patients Treated by Bilateral M1-iTBS [NA]

See pricing